IntoCell Enters into Development and License Option Agreement with ADC Therapeutics

Go back to IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
ADC TELECOMM (NYSE: ADCT) Delayed: 1.50 +0.06 (4.17%)
Previous Close $1.44    52 Week High $12.76 
Open $1.45    52 Week Low $5.18 
Day High $1.54    P/E 1.92 
Day Low $1.43    EPS $0.78 
Volume 246,784